Palisade Bio Files 8-K: Financial Statements and Exhibits
Ticker: PALI · Form: 8-K · Filed: Oct 9, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Oct 9, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financials
TL;DR
Palisade Bio filed an 8-K with financial docs, nothing major to see here.
AI Summary
On October 9, 2025, Palisade Bio, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The company, formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc., is incorporated in Delaware and headquartered in Carlsbad, California.
Why It Matters
This 8-K filing indicates the submission of financial statements and exhibits, which are routine but necessary for regulatory compliance and investor information.
Risk Assessment
Risk Level: low — The filing is a routine submission of financial statements and exhibits, not indicating any new risks or significant events.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- October 9, 2025 (date) — Date of earliest event reported
- Seneca Biopharma, Inc. (company) — Former company name
- Neuralstem, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of Incorporation
- Carlsbad, California (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Palisade Bio, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 9, 2025.
What were Palisade Bio, Inc.'s former company names?
Palisade Bio, Inc. was formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc.
In which state is Palisade Bio, Inc. incorporated?
Palisade Bio, Inc. is incorporated in Delaware.
What is the principal executive office address for Palisade Bio, Inc.?
The principal executive office address for Palisade Bio, Inc. is 1902 Wright Place, Suite 200, Carlsbad, California, 92008.
Filing Stats: 472 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-10-09 17:08:01
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Marke
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 6KB
- ex99-1_001.jpg (GRAPHIC) — 13KB
- 0001493152-25-017630.txt ( ) — 225KB
- pali-20251009.xsd (EX-101.SCH) — 3KB
- pali-20251009_lab.xml (EX-101.LAB) — 33KB
- pali-20251009_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 9, 2025 Palisade Bio, Inc. /s/ J.D. Finley By: J.D. Finley Chief Executive Officer